In this pathway, downstream mediators including iPLA2, PGE2, 15-keto PGE2, and PPARγ have all been shown to enhance CLDN1 transcription in A549 cells (20), highlighting the tight junction protein’s involvement in inflammation-driven tumor progression. The gene discussed is CLDN1; the disease is neoplasm.